IGC Pharma, Inc. (IGC)
Official siteHEALTHCARE • BIOTECHNOLOGY • AMEX
Market Cap: $20.42M
Last updated: Nov 17, 2026 at 4:38 PM ET
IGC Pharma, Inc. (IGC) Stock Chart
IGC Pharma (IGC) has a latest price of $0.19 on Nov 17, 2026, 48.4% below its 52-week high of $0.36. Its price fell 52.2% over the past 12 months. The month-end price fell 55.7% over the 10 years through Oct 2026, a compound annual decline of 7.8%.
Price Chart
From Oct 2016 to Oct 2026, its highest month-end close was $6.45 in Sep 2018 and its lowest $0.18 in Oct 2026, adjusted for splits.
Month-end closes, adjusted for splits. Dividends are not included.
Chart IGC with Advanced Charting
Daily candlesticks, valuation multiples, side-by-side comparisons and drawings for IGC.
Free with a GNG account. No credit card.
Price Performance
Over the past 3 months the price fell 27.6%, and over 6 months it fell 41.7%. The month-end price fell 38.3% over the 3 years through Oct 2026, a compound annual decline of 14.9%.
| Period | Change |
|---|---|
| 1 month | -33.6% |
| 3 months | -27.6% |
| 6 months | -41.7% |
| 12 months | -52.2% |
| 12 months, with dividends | -52.2% |
| Period | Change | Per year |
|---|---|---|
| 3 years | -38.3% | -14.9% |
| 5 years | -86.8% | -33.3% |
| 10 years | -55.7% | -7.8% |
Price by Year
Its best calendar year was 2017, when the price rose 257.1%, and its weakest was 2018, when it fell 72.0%.
| Year | Close | Change |
|---|---|---|
| 2026 through Oct 2026 | $0.18 | -34.3% |
| 2025 | $0.28 | -16.3% |
| 2024 | $0.34 | +20.0% |
| 2023 | $0.28 | -11.9% |
| 2022 | $0.32 | -67.4% |
| 2021 | $0.98 | -37.4% |
| 2020 | $1.56 | +147.6% |
| 2019 | $0.63 | +125.0% |
| 2018 | $0.28 | -72.0% |
| 2017 | $1.00 | +257.1% |
Trading Range
The price is 24.4% below its 50-day average of $0.25 and 32.1% below its 200-day average of $0.27.
| Measure | Value | Price vs |
|---|---|---|
| Latest price (Nov 17, 2026) | $0.19 | |
| 52-week high | $0.36 | -48.4% |
| 52-week low | $0.17 | +10.7% |
| 50-day average | $0.25 | -24.4% |
| 200-day average | $0.27 | -32.1% |
Price Risk
Over 3 years, its largest fall from a peak was 73.2%.
| Measure | Value |
|---|---|
| 1-year beta | 1.16 |
| Largest fall, 1 year | -52.6% |
| Largest fall, 3 years | -73.2% |
Advanced Charting Features
Advanced Charting is free with a GNG account, and signed-in members get it in place of the price chart above.
- Valuation multiples. Daily P/E, price to sales, cash flow and book value, PEG and PEGY, drawn behind the price wherever the company's data supports them.
- Price charts and drawings. Candlestick, OHLC, line and area charts with volume and earnings, dividend and split markers, plus trend lines, levels and notes kept in your account.
- Side-by-side compare. Two stocks next to each other on one metric and time span, each chart with its own price scale.
- Projections and saved views. Pick a start and an end point to see the price return, dividends and total return between them, and save views to open later.
Frequently Asked Questions About IGC
What is IGC's 1-year price change?
IGC Pharma's price fell 52.2% over the past 12 months. With dividends included, the 12-month total return was -52.2%.
What is IGC's 5-year price change?
IGC Pharma's month-end price fell 86.8% over the 5 years through Oct 2026, a compound annual decline of 33.3%. These figures leave out dividends.
What is IGC's 52-week high and low?
IGC Pharma's 52-week high is $0.36 and its 52-week low is $0.17. Its latest price of $0.19 on Nov 17, 2026 is 48.4% below the high.
What is IGC's beta?
IGC Pharma's 1-year beta against the S&P 500 is 1.16, so its price has moved about in line with the market over the past year. Its largest fall from a peak over the past year was 52.6%.
Is the IGC chart free?
Yes. Advanced Charting for IGC is free with a GNG account, and no credit card is needed. It adds daily candlestick and line charts with volume, valuation multiples, side-by-side comparisons, drawings and saved views.
IGC pages: Overview, Charting, Earnings, Forecast, Financials, Statistics, Competitors